UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults

Haematologica (Roma), 2020-12, Vol.105 (12), p.2841-2843

2020

Volltextzugriff (PDF)

ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

Current oncology (Toronto), 2022-01, Vol.29 (2), p.641-658

2022

Volltextzugriff (PDF)

An Outbreak of Covid-19 on an Aircraft Carrier

The New England journal of medicine, 2021-03, Vol.384 (10), p.976-977

2021

Volltextzugriff (PDF)

Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer

Targeted oncology, 2017-10, Vol.12 (5), p.563-569

2017

Volltextzugriff (PDF)

Performances, feasibility and acceptability of nasopharyngeal swab, saliva and oral-self sampling swab for the detection of severe acute respiratory syndrome coronavirus 2

European journal of clinical microbiology & infectious diseases, 2021-10, Vol.40 (10), p.2191-2198

2021

Volltextzugriff (PDF)

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients

International journal of infectious diseases, 2021-11, Vol.112, p.8-12

2021

Volltextzugriff (PDF)

Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)

Current oncology (Toronto), 2021-09, Vol.28 (5), p.3804-3811

2021

Volltextzugriff (PDF)

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients

Cancers, 2021-03, Vol.13 (5), p.1040

2021

Volltextzugriff (PDF)

Incidence and Management of Anastomotic Complications After Bronchial Resection: A Retrospective Study

The Annals of thoracic surgery, 2014-12, Vol.98 (6), p.1961-1967

2014

Volltextzugriff (PDF)

Stay and play eFAST or scoop and run eFAST? That is the question

The American journal of emergency medicine, 2014-02, Vol.32 (2), p.166-170

2014

Volltextzugriff (PDF)

Second- or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: Results of the IFCT-1501 MAPS2 randomized phase II trial

Journal of clinical oncology, 2017-06, Vol.35 (18_suppl), p.LBA8507-LBA8507

2017

Volltextzugriff (PDF)

Second- or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: Results of the IFCT-1501 MAPS2 randomized phase II trial

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.LBA8507-LBA8507

2017

Volltextzugriff (PDF)

Positive FDG-PET/CT of the Pleura Twenty Years after Talc Pleurodesis: Three Cases of Benign Talcoma

Respiration, 2014-01, Vol.87 (3), p.243-248

2014

Volltextzugriff (PDF)

Assessing the Multimodal Management of Advanced Solitary Fibrous Tumors of the Pleura in a Routine Practice Setting

Journal of thoracic oncology, 2015-02, Vol.10 (2), p.309-315

2015

Volltextzugriff (PDF)

Endobronchial Treatment of Complete Tracheal Stenosis: Report of 3 Cases and Description of an Innovative Technique

The Annals of thoracic surgery, 2013, Vol.95 (1), p.351-354

2013

Volltextzugriff (PDF)

ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults

Haematologica (Roma), 2020-12, Vol.105 (12), p.2841

2020

Volltextzugriff (PDF)

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

The New England journal of medicine, 2023-08, Vol.389 (6), p.491-503

2023

Volltextzugriff (PDF)

Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018

Journal of thoracic oncology, 2020-04, Vol.15 (4), p.628-636

2020

Volltextzugriff (PDF)

Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study

Nicotine & tobacco research, 2021-08, Vol.23 (8), p.1398-1404

2021

Volltextzugriff (PDF)

Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2023, Vol.37 (1), p.121-121

2023

Volltextzugriff (PDF)

Reply to “Better Prognostic Models May Result in Improved Patient Selection for Adjuvant Therapies After Complete Resection of Solitary Fibrous Tumors of the Pleura”

Journal of thoracic oncology, 2015-07, Vol.10 (7), p.e61-e62

2015

Volltextzugriff (PDF)

Reply to “Better Prognostic Models May Result in Improved Patient Selection for Adjuvant Therapies After Complete Resection of Solitary Fibrous Tumors of the Pleura”

Journal of thoracic oncology, 2015-06, Vol.10 (6), p.e53-e54

2015

Volltextzugriff (PDF)

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

The New England journal of medicine, 2023-11, Vol.389 (18), p.1672-1684

2023

Volltextzugriff (PDF)

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2022-03, Vol.36 (2), p.137-151

2022

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(71)

Publikationsform

Artikel
(75)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(50)
Science & Technology
(50)
Humans
(37)
Oncology
(30)
Life Sciences
(29)
Male
(24)
Female
(22)
Middle Aged
(18)
Lung Cancer
(17)
Lung Neoplasms - Drug Therapy
(16)
Cancer
(15)
Chemotherapy
(15)
Adult
(14)
Respiratory System
(14)
Aged
(13)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(12)
Lung Neoplasms - Pathology
(12)
Carcinoma, Non-Small-Cell Lung - Pathology
(11)
General & Internal Medicine
(11)
Immunotherapy
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults

ROS-1 Fusions in Non-Small-Cell Lung Cancer: Evidence to Date

An Outbreak of Covid-19 on an Aircraft Carrier

Targeting the PD-1/PD-L1 Immune Checkpoint in EGFR-Mutated or ALK-Translocated Non-Small-Cell Lung Cancer

Performances, feasibility and acceptability of nasopharyngeal swab, saliva and oral-self sampling swab for the detection of severe acute respiratory syndrome coronavirus 2

Neutralizing antibody response to SARS-CoV-2 persists 9 months post symptom onset in mild and asymptomatic patients

Feasibility of Stereotactic Body Radiation Therapy on Unresectable Stage III NSCLC with Peripheral Primary Tumor: A Prospective Study (GFPC 01-14)

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients

Incidence and Management of Anastomotic Complications After Bronchial Resection: A Retrospective Study

Stay and play eFAST or scoop and run eFAST? That is the question

Second- or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: Results of the IFCT-1501 MAPS2 randomized phase II trial

Second- or third-line nivolumab (Nivo) versus nivo plus ipilimumab (Ipi) in malignant pleural mesothelioma (MPM) patients: Results of the IFCT-1501 MAPS2 randomized phase II trial

Positive FDG-PET/CT of the Pleura Twenty Years after Talc Pleurodesis: Three Cases of Benign Talcoma

Assessing the Multimodal Management of Advanced Solitary Fibrous Tumors of the Pleura in a Routine Practice Setting

Endobronchial Treatment of Complete Tracheal Stenosis: Report of 3 Cases and Description of an Innovative Technique

ABO blood groups are not associated with risk of acquiring the SARS-CoV-2 infection in young adults

Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial

Efficacy and Safety of Anti–PD-1 Immunotherapy in Patients With Advanced NSCLC With BRAF, HER2, or MET Mutations or RET Translocation: GFPC 01-2018

Impact of Tobacco Smoking on the Risk of COVID-19: A Large Scale Retrospective Cohort Study

Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

Reply to “Better Prognostic Models May Result in Improved Patient Selection for Adjuvant Therapies After Complete Resection of Solitary Fibrous Tumors of the Pleura”

Reply to “Better Prognostic Models May Result in Improved Patient Selection for Adjuvant Therapies After Complete Resection of Solitary Fibrous Tumors of the Pleura”

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

Suchergebnisse filtern